Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Q Biomed Inc (QBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 48,405
  • Shares Outstanding, K 13,990
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,540 K
  • 36-Month Beta 1.88
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 13.25
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.54
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 07/18/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.0500 +13.11%
on 05/24/18
3.6500 -5.48%
on 06/04/18
+0.3500 (+11.29%)
since 05/22/18
3-Month
2.8600 +20.63%
on 05/03/18
3.9500 -12.66%
on 04/05/18
+0.4000 (+13.11%)
since 03/22/18
52-Week
2.7300 +26.37%
on 02/13/18
5.9000 -41.53%
on 11/30/17
-0.6800 (-16.46%)
since 06/22/17

Most Recent Stories

More News
Q BioMed Inc. Provides Important Update on Mannin Research Tie2 Technology Platform Development

NEW YORK , June 6, 2018 /PRNewswire/ --

QBIO : 3.4500 (-0.29%)
Q BioMed Inc. Provides Important Update on Mannin Research Tie2 Technology Platform Development

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, provides the following update on its exclusively licensed platform technology asset from Mannin Research...

QBIO : 3.4500 (-0.29%)
Q BioMed Inc Places 2nd in Company Category for Autism Speaks Walk Fundraiser

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, placed second in the 'company category' at this year's Bay Area Autism Speaks Walk. The fundraiser provided Q BioMed an opportunity to...

QBIO : 3.4500 (-0.29%)
Q Biomed Inc. to Present at the Microcap Conference Taking Place April 9-10 at the Essex House in New York City

NEW YORK , April 5, 2018 /PRNewswire/ --

QBIO : 3.4500 (-0.29%)
Q Biomed Inc. to Present at the Microcap Conference Taking Place April 9-10 at the Essex House in New York City

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration company, announced today that Denis Corin, Chief Executive Officer, will present at the MicroCap Conference being held at the...

QBIO : 3.4500 (-0.29%)
Significant Progress in Non-opioid Therapy Picks up Steam as Market Projected to Reach $22 Billion by 2022

MarketNewsUpdates.com News Commentary

SRNE : 6.55 (+6.50%)
QBIO : 3.4500 (-0.29%)
DRRX : 1.95 (-1.52%)
PTI : 3.10 (+5.80%)
VRTX : 159.19 (+1.67%)
Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Strontium Chloride SR89 Injection USP for Relief of Cancer Bone Pain

NEW YORK , March 16, 2018 /PRNewswire/ --

QBIO : 3.4500 (-0.29%)
Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Strontium Chloride SR89 Injection USP for Relief of Cancer Bone Pain

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, and Bio-Nucleonics, licensor of Strontium 89 Chloride, announce submission of a regulatory filing to the...

QBIO : 3.4500 (-0.29%)
Q BioMed Inc. to Present at 30th Annual Roth Conference, Taking Place March 11-14, 2018, in Dana Point, CA

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration company, announced today that Denis Corin, Chief Executive Officer will present at the 30th Annual Roth Conference, being held...

QBIO : 3.4500 (-0.29%)
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market presenting companies...

KSHB : 5.1100 (+0.29%)
EVLLF : 0.7640 (-6.49%)
OPRX : 10.40 (+0.29%)
DMIFF : 0.2900 (-3.33%)
CORVF : 1.7697 (+1.71%)
IMPZY : 1.6000 (unch)
CHPE : 18.1250 (+0.14%)
CBWTF : 0.9600 (-4.81%)
ATMS : 1.0101 (unch)
RSSS : 1.7000 (-0.58%)
FSSN : 0.1700 (+3.03%)
MSRT : 0.2500 (-1.96%)
GPVRF : 0.5192 (+0.44%)
QBIO : 3.4500 (-0.29%)
SNYR : 0.3350 (+4.69%)
ACBFF : 7.5300 (-4.32%)
CVSI : 1.6300 (+17.27%)
RSASF : 0.3020 (-22.44%)
COSM : 6.1500 (+8.85%)
GRWG : 4.2700 (-0.47%)
GTBP : 2.0500 (+0.49%)
ZYXI : 3.1000 (-6.06%)
PURE : 0.7000 (+16.67%)
CXDO : 2.7500 (+3.77%)
BCTXF : 0.1300 (+1.56%)
TAOIF : 0.3082 (+3.81%)
BNOEF : 0.3950 (+3.03%)
NMKEF : 0.6820 (+7.69%)
CNNRF : 4.0300 (-0.98%)
ZEST : 1.4500 (-3.33%)
HEOFF : 0.9007 (-2.43%)
ITHUF : 5.6246 (-2.18%)
COTQF : 0.3740 (-4.30%)
OTCM : 27.8100 (-3.34%)
DCTH : 2.8000 (+1.82%)
AEYE : 0.2310 (+0.43%)
VFFIF : 5.6657 (-1.64%)
TITXF : 0.1930 (-1.03%)
NMGRF : 0.2313 (+3.63%)
GLDLF : 0.6800 (+1.49%)
SNNVF : 5.9500 (+0.90%)
IWSY : 1.3100 (-0.76%)
ARTH : 0.4640 (+1.98%)
IRNC : 0.7000 (-23.08%)
PNGZF : 0.1650 (+13.79%)
NTSFF : 0.9154 (-1.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade QBIO with:

Key Turning Points

2nd Resistance Point 3.5900
1st Resistance Point 3.5200
Last Price 3.4500
1st Support Level 3.3800
2nd Support Level 3.3100

See More

52-Week High 5.9000
Fibonacci 61.8% 4.6891
Fibonacci 50% 4.3150
Fibonacci 38.2% 3.9409
Last Price 3.4500
52-Week Low 2.7300

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar